Ischemic stroke laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
Line 11: | Line 11: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Complete blood count | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* To look for underlying infection (leukocytosis) | |||
* [[Thrombocytosis]] and [[thrombocytopenia]] | |||
* [[Polycythemia]] | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Lipid profile | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Increased LDL, triglycerides and cholesterol increases risk for ischemic stroke | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |PT/APTT | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |To rule out underlying bleeding risk for anticoagulant administration | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |BUN/Creatinine | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Renal function tests to look for underlying kidney disease | ||
|- | |||
|Serum homocystein level | |||
|Increased levels associated with increased risk of thromboembolic event | |||
|- | |||
|BMP | |||
|To rule out electrolyte abnormalities which may mimic or complicate ischemic stroke | |||
|- | |||
|HbA1C | |||
|Underlying diabetes mellitus, major risk factor for ischemic stroke | |||
|- | |||
|Blood glucose levels | |||
|Hyperglycemia is associated with poor prognosis of ischemic stroke | |||
|- | |||
|Cardiac enzymes | |||
|To rule out underlying coronary artery disease | |||
|- | |||
|Pregnancy test | |||
|To rule out pregnancy in female patients with ischemic stroke as t-PA is a class C agent. | |||
|- | |- | ||
|} | |} | ||
* | * | ||
==References== | ==References== |
Revision as of 15:20, 15 November 2016
Ischemic Stroke Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ischemic stroke laboratory findings On the Web |
American Roentgen Ray Society Images of Ischemic stroke laboratory findings |
Risk calculators and risk factors for Ischemic stroke laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Laboratory Findings
Labortary tests may help determine the risk factors complications of ischemic stroke. Blood tests which may be performed include:
Blood test | Reason |
---|---|
Complete blood count |
|
Lipid profile | Increased LDL, triglycerides and cholesterol increases risk for ischemic stroke |
PT/APTT | To rule out underlying bleeding risk for anticoagulant administration |
BUN/Creatinine | Renal function tests to look for underlying kidney disease |
Serum homocystein level | Increased levels associated with increased risk of thromboembolic event |
BMP | To rule out electrolyte abnormalities which may mimic or complicate ischemic stroke |
HbA1C | Underlying diabetes mellitus, major risk factor for ischemic stroke |
Blood glucose levels | Hyperglycemia is associated with poor prognosis of ischemic stroke |
Cardiac enzymes | To rule out underlying coronary artery disease |
Pregnancy test | To rule out pregnancy in female patients with ischemic stroke as t-PA is a class C agent. |